Cargando…

Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report

BACKGROUND: Although tumors of the lacrimal sac are rare, they represent a potentially life-threatening situation that can easily be overlooked since patients present with features consistent with chronic dacryocystitis. Lacrimal sac squamous cell carcinoma is the most common lacrimal sac malignancy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ming-Hui, Yi, Wei-Dong, Shen, Ling, Zhou, Lu, Lu, Jian-Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353896/
https://www.ncbi.nlm.nih.gov/pubmed/36157994
http://dx.doi.org/10.12998/wjcc.v10.i21.7467
_version_ 1784762951996014592
author Sun, Ming-Hui
Yi, Wei-Dong
Shen, Ling
Zhou, Lu
Lu, Jian-Xun
author_facet Sun, Ming-Hui
Yi, Wei-Dong
Shen, Ling
Zhou, Lu
Lu, Jian-Xun
author_sort Sun, Ming-Hui
collection PubMed
description BACKGROUND: Although tumors of the lacrimal sac are rare, they represent a potentially life-threatening situation that can easily be overlooked since patients present with features consistent with chronic dacryocystitis. Lacrimal sac squamous cell carcinoma is the most common lacrimal sac malignancy, but no definitive treatment is currently available. CASE SUMMARY: We describe a 34-year-old unmarried male who presented with a red and swollen right lower eyelid, which gradually developed into a mass of the lower eyelid that obstructed vision in his right eye. He was treated with transcatheter arterial infusion chemotherapy and interventional embolization based on the tumor characteristics, and we also administered intensity-modulated radiotherapy and targeted therapy after tumor shrinkage. The tumor treatment demonstrated good efficacy, and the patient’s condition was stable after 10 mo of follow-up. CONCLUSION: To our knowledge, this is the first report of lacrimal sac squamous cell carcinoma treated with transcatheter arterial infusion chemotherapy and interventional embolization, which might expand clinical treatment options for lacrimal sac carcinoma.
format Online
Article
Text
id pubmed-9353896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-93538962022-09-23 Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report Sun, Ming-Hui Yi, Wei-Dong Shen, Ling Zhou, Lu Lu, Jian-Xun World J Clin Cases Case Report BACKGROUND: Although tumors of the lacrimal sac are rare, they represent a potentially life-threatening situation that can easily be overlooked since patients present with features consistent with chronic dacryocystitis. Lacrimal sac squamous cell carcinoma is the most common lacrimal sac malignancy, but no definitive treatment is currently available. CASE SUMMARY: We describe a 34-year-old unmarried male who presented with a red and swollen right lower eyelid, which gradually developed into a mass of the lower eyelid that obstructed vision in his right eye. He was treated with transcatheter arterial infusion chemotherapy and interventional embolization based on the tumor characteristics, and we also administered intensity-modulated radiotherapy and targeted therapy after tumor shrinkage. The tumor treatment demonstrated good efficacy, and the patient’s condition was stable after 10 mo of follow-up. CONCLUSION: To our knowledge, this is the first report of lacrimal sac squamous cell carcinoma treated with transcatheter arterial infusion chemotherapy and interventional embolization, which might expand clinical treatment options for lacrimal sac carcinoma. Baishideng Publishing Group Inc 2022-07-26 2022-07-26 /pmc/articles/PMC9353896/ /pubmed/36157994 http://dx.doi.org/10.12998/wjcc.v10.i21.7467 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Case Report
Sun, Ming-Hui
Yi, Wei-Dong
Shen, Ling
Zhou, Lu
Lu, Jian-Xun
Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report
title Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report
title_full Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report
title_fullStr Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report
title_full_unstemmed Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report
title_short Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report
title_sort transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353896/
https://www.ncbi.nlm.nih.gov/pubmed/36157994
http://dx.doi.org/10.12998/wjcc.v10.i21.7467
work_keys_str_mv AT sunminghui transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport
AT yiweidong transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport
AT shenling transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport
AT zhoulu transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport
AT lujianxun transcatheterarterialinfusionchemotherapyandembolizationforprimarylacrimalsacsquamouscellcarcinomaacasereport